Search
View Show Page
JACC Specialty Journals
JACC: Basic to Translational Science - Effect of Crizanlizumab, a P-selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
Dec 27, 2021
6:26
Save
Follow
Share
Science
Episode Description
Commentary by Dr. Douglas Mann
Listen On
How to rate & review on Apple Podcasts
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows